Bronchiectasis in Childhood

Vikas Goyal1, Anne B Chang2

  • 1Department of Respiratory and Sleep Medicine, Queensland Children's Hospital, Brisbane, Queensland, Australia; Department of Pediatrics, Gold Coast Health, Gold Coast, Australia; Australian Centre for Health Services Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.

Insights

Pediatric bronchiectasis, a cause of chronic wet cough, involves infection and inflammation. Research is shifting towards prevention and novel treatments for this serious childhood lung condition.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Medicine
  • Child Health

Background:

  • Bronchiectasis is a key diagnosis in pediatric chronic wet cough, associated with significant morbidity and mortality.
  • Its pathobiology features a cycle of infection, inflammation, immune dysregulation, and airway remodeling, leading to impaired clearance and obstruction.
  • Current pediatric research is limited, with a recent emphasis on antibiotic roles in exacerbation management.

Purpose of the Study:

  • To highlight the current understanding of pediatric bronchiectasis pathobiology.
  • To underscore the need for more pediatric-specific research.
  • To focus on emerging strategies for bronchiectasis prevention and novel therapeutic approaches in children.

Main Methods:

  • Review of existing pediatric pathobiological data.
  • Analysis of recent findings on antibiotic use in exacerbations.
  • Exploration of current research trends in prevention and novel drug development.

Main Results:

  • The pathobiology involves a detrimental cycle impacting airway structure and function.
  • There is a recognized gap in pediatric-specific pathobiological studies.
  • Antibiotics play a role in managing exacerbations, but focus is shifting to prevention.

Conclusions:

  • Understanding the pathobiology is crucial for developing effective interventions.
  • Further pediatric research is essential to address knowledge gaps.
  • Novel strategies are needed for the prevention and treatment of pediatric bronchiectasis.

Related Concept Videos

Pulmonary Cycle: Exhalation01:17

Pulmonary Cycle: Exhalation

In terms of human respiration, the act of expelling air, known as exhalation (or expiration), operates on the principle of pressure gradients. During expiration, the pressure within the lungs exceeds that of the surrounding atmosphere. Under normal conditions, quiet breathing involves passive exhalation and is free of muscular contractions. This is because the exhalation process is driven by the natural elastic recoil of the lungs and chest wall, both of which have an inherent tendency to...
1.9K
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
384
The Bronchial Tree01:23

The Bronchial Tree

The human bronchi and bronchial tree play a crucial role in the respiratory system, facilitating the exchange of oxygen and carbon dioxide. Let's delve into the intricate structure and functions of these respiratory components.
The trachea, commonly known as the windpipe, is a tube that connects the larynx (voice box) to the bronchi. At a point called the carina, it bifurcates into two primary bronchi. The right primary bronchus is wider, shorter, and more vertical than the left primary...
4.0K
Pulmonary Tuberculosis II01:28

Pulmonary Tuberculosis II

Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
514
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
232
Pulmonary Tuberculosis I01:29

Pulmonary Tuberculosis I

Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
358